The objective of this study is to determine the economic evaluation of the treatment of chronic hepatitis B by using drugs that are currently available in Thailand, and to analyze the budget impact in listing drugs with cleared health economic evaluation into the National List of Essential Medicines.  01-340-2552

Patients with Down’s syndrome have developmental delay and abnormalities in their biological system. Most of the patients cannot take care of themselves. They must have long term treatment which is quite expensive. Currently there is no curative therapy for Down’s syndrome. Screening and prenatal diagnosis to detect abnormalities of Down’s sy

The debate over the price of the vaccine against HPV has become intenseWhen it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Human

There is uncertainty as to whether the use of insulin analogues is justified for all or some diabetic groups since they are more expensive than conventional insulin. This article draws its conclusions from a systematic review and a meta-analysis, which were undertaken to evaluate the clinical and economic implications of using insulin analogues for

At the 67th World Health Assembly in Geneva in May 2014, a resolution was adopted on Health intervention and technology assessment in support of universal health coverage. Prof David Haslam, Chair of NICE, representing the UK Mission Geneva, addressed the Assembly during a panel session on the role

I have had the unique opportunity to be an international fellow with Thailand’s Health Interventions and Technology Assessment Program (HITAP) for the last five months between February and June 2015. While the task of chronicling the invaluable experiences I have gained in this short time is a daunt

Quality and Outcomes Framework Steering Meeting 15 March 2016 Thailand adopted in 2013 the Quality and Outcomes Framework, also known as the QOF. This program was initiated by the National Health Security Office (NHSO) in Thailand that is responsi

From 23rd to 25th February 2018, three members from HITAP’s International Unit (HIU) went to Chandigarh, India. Two separate events occurred in Chandigarh during this time. The first was the 7th International Fellowship on Health Technology Assessment, a week-long HTA training workshop from 19th to

How can countries build the systems that can deliver universal health coverage whilst juggling a whole host of challenges, constraints and demands? The short answer? They need to make choices, smart choices that are built on careful and evidence-based priority setting practices.

Last January, I had an opportunity to attend a training and symposium entitled ‘Health Technology Assessment: selecting the highest value care’ organized by the Saw Swee Hock School of Public Health, National University of Singapore (NUS), and the Health Intervention and Technology Assessment Progra